NCT07218913 2026-01-26
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
City of Hope Medical Center
Phase 1 Recruiting
Clinical Trials
5 trialsNCT04262336 2023-07-06
Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment
Decibel Therapeutics
Phase 1 Completed
NCT02094625 2023-04-18
NAC to Prevent Cisplatin-induced Hearing Loss
Children's Hospital Los Angeles
Phase 1 Completed
NCT01452607 2016-06-29
Study to Evaluate the Safety and Pharmacokinetics of SPI-1005
Sound Pharmaceuticals, Incorporated
Phase 1 Completed
NCT00584155 2015-05-27
Protection From Cisplatin Ototoxicity by Lactated Ringers
University of Oklahoma
Phase 1 Withdrawn